Details for Patent: 6,342,530

Summary for Patent: 6,342,530

Title:	Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt
Abstract:	Pharmaceutical compositions are disclosed suitable for parenteral administration having anti-inflammatory, analgesic, and anti-pyretic properties, which consist of a therapeutically effective amount of d,l or l-lysine salt of R,S or S-ibuprofen as active ingredient dissolved in sterile water to form a solution in the absence of an inert atmosphere and either substantially free or absolutely free of any excipient, organic solvent, buffer, acid, base, salt other than the active ingredient and capable of storage in the absence of an inert atmosphere. Also disclosed are methods employing the new compositions in the treatment of pain and inflammation, in reducing fever and in treating patent ductus arterious or intraventricular hemorrhage in prematurely born neonates.
Inventor(s):	Darko; Laszlo (Westport, CT)
Assignee:	Farmacon-Il, LLC (Westport, CT)
Application Number:	09/712,430
Patent Claim Types: see list of patent claims	Composition; Formulation; Dosage form; Use;

Drugs Protected by US Patent 6,342,530

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

International Family Members for US Patent 6,342,530

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	293444
Canada	2361160
Germany	60110185
European Patent Office	1205181